Nuvelo(NUVO) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nuvelo(NUVO)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote (41)	8/22/2005 8:14:38 AM
From: Arthur Radley	Read Replies (1) of 140

Apparently very few here follow this company, but IMO it is a biotech hitting on all cylinders. It is hard to find a biotech trading in the single digits and have the pipeline potential that they have. With one Phase III trial underway, another starting any moment, and one additional Phase III that should start before year end, another drug moving into Phase II and finally a internal drug that should move into INDs early in 2006...strong management and financial position makes this stock undervalued IMO. Plus, news out today on the start of a Phase 11 'Proof of Concept' trial for a medical condition that accounts for more that 1 million hospitalizations a year in the US alone... biz.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next